c-Kit-IN-3

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

c-Kit-IN-3 是一种选择性 c-KIT 激酶抑制剂，对于 c-Kit (wt) 和 c-Kit (T670I) 的 IC50 分别为 4 nM 和 8 nM。

c-Kit-IN-3 is a selective inhibitor of c-KIT kinase with IC50s of 4 nM and 8 nM for c-Kit (wt) and c-Kit (T670I).(In Vitro):In primary GIST patient cells, c-Kit-IN-3 (0.1-10 μM) exhibits dose-dependent antiproliferative effects. In GIST-T1, GIST-T1-T670I, and GIST-5R cells, c-Kit-IN-3 (0.01-1 μM) induces dose-dependent cell apoptotic death and arrests the cell cycle into the G0/G1 phase.(In Vivo):c-Kit-IN-3 (1 mg/kg i.v. for mice, rats, dog; 10 mg/kg p.o. for mice, rats; 5 mg/kg p.o. for dog) has T1/2 of 4.5 h, 6.4 h, 19.4 h for mice, rats and dogs, respectively. c-Kit-IN-3 possesses acceptable bioavailability of 43%, 50% and 81% for mice, rats, and dogs. In female BALB/C-nu mice, c-Kit-IN-3 (20-100 mg/kg; gavage) treatment dose-dependently inhibits the tumor progression.

——

——

——

Angiogenesis

c-Kit

——

——

——

2363169-01-9

516.9

C26H20ClF3N2O4

>98% (HPLC)

——

COc1cc2nccc(Oc3ccc(NC(=O)Cc4ccc(Cl)c(c4)C(F)(F)F)cc3)c2cc1OC

——

(-20℃)

With Ice Pack

≥ 2 years